Aurinia Pharmaceuticals Inc Earnings

Aurinia Pharmaceuticals Inc’s revenue jumped 28.81% since last year same period to $77.11Mn in the Q4 2025. On a quarterly growth basis, Aurinia Pharmaceuticals Inc has generated 4.96% jump in its revenue since last 3-months.

Aurinia Pharmaceuticals Inc’s net profit jumped 14651.15% since last year same period to $210.79Mn in the Q4 2025. On a quarterly growth basis, Aurinia Pharmaceuticals Inc has generated 568.11% jump in its net profits since last 3-months.

Aurinia Pharmaceuticals Inc’s net profit margin jumped 11351.97% since last year same period to 273.35% in the Q4 2025. On a quarterly growth basis, Aurinia Pharmaceuticals Inc has generated 536.52% jump in its net profit margins since last 3-months.

Aurinia Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.16 - a 4.37% jump from last quarter’s estimates.

Aurinia Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.16.

Aurinia Pharmaceuticals Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Aurinia Pharmaceuticals Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.